Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27534 | 186 | 32.9 | 75% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TUMOR CLONALITY | Author keyword | 2 | 40% | 2% | 4 |
| 2 | CLONAL REMISSION | Author keyword | 1 | 50% | 1% | 2 |
| 3 | M27 BETA | Author keyword | 1 | 100% | 1% | 2 |
| 4 | TUMOUR CLONALITY | Author keyword | 1 | 100% | 1% | 2 |
| 5 | HUMAN ANDROGEN RECEPTOR GENE | Author keyword | 1 | 20% | 2% | 4 |
| 6 | HUMAN ANDROGEN RECEPTOR GENE HUMARA | Author keyword | 1 | 33% | 1% | 2 |
| 7 | HUMARA ASSAY | Author keyword | 1 | 23% | 2% | 3 |
| 8 | ANDROGEN RECEPTOR GENE HUMARA | Author keyword | 1 | 50% | 1% | 1 |
| 9 | ATYPICAL MELANOCYTIC NEVUS | Author keyword | 1 | 50% | 1% | 1 |
| 10 | HUMAN ANDROGEN RECEPTOR HUMARA | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SOMATIC DOWN REGULATION | 6 | 100% | 2% | 4 |
| 2 | M27 BETA | 5 | 31% | 8% | 15 |
| 3 | PROBE M27 BETA | 5 | 63% | 3% | 5 |
| 4 | FOLLICULAR THYROID NEOPLASMS | 4 | 75% | 2% | 3 |
| 5 | TOPOGRAPHIC COMPARTMENTS | 3 | 57% | 2% | 4 |
| 6 | LOCUS DXS255 | 2 | 29% | 3% | 5 |
| 7 | CLONAL DEVELOPMENT | 2 | 43% | 2% | 3 |
| 8 | HYPERVARIABLE PROBE M27 BETA | 1 | 40% | 1% | 2 |
| 9 | CELL POOL | 1 | 50% | 1% | 1 |
| 10 | CLONAL DIVERGENCE | 1 | 50% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Many different tumor types have polyclonal tumor origin: Evidence and implications | 2008 | 25 | 119 | 13% |
| Analysis of clonal cell growth using X-chromosome inactivation patterns | 1998 | 1 | 44 | 34% |
| Characterization of adjacent breast tumors using oligonucleotide microarrays | 2001 | 32 | 8 | 13% |
| The clonal origin and clonal evolution of epithelial tumours | 2000 | 37 | 293 | 12% |
| Monoclonality of endocrine tumours: what does it mean? | 2001 | 13 | 87 | 16% |
| General morphological and biological features of neoplasms: integration of molecular findings | 2008 | 14 | 92 | 9% |
| Use of laser capture microdissection for clonal analysis | 2002 | 1 | 34 | 15% |
| Pathological Bases for a Robust Application of Cancer Molecular Classification | 2015 | 0 | 95 | 9% |
| ASSESSMENT OF CLONALITY IN HUMAN TUMORS - A REVIEW | 1990 | 119 | 63 | 13% |
| Tumor Heterogeneity: Mechanisms and Bases for a Reliable Application of Molecular Marker Design | 2012 | 23 | 272 | 5% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INVEST PATHOBIOL MOL | 1 | 50% | 0.5% | 1 |
| 2 | MANCHESTER ROYAL INFIRM HAEMATOL | 1 | 50% | 0.5% | 1 |
| 3 | ESA 8067 | 0 | 14% | 0.5% | 1 |
| 4 | BARTS LONDON QUEEN MARYS MED | 0 | 10% | 0.5% | 1 |
| 5 | DENT ORAL SURG PATHOL | 0 | 100% | 0.5% | 1 |
| 6 | FAK MEDBEREICH MOL BIOLMED KLIN | 0 | 100% | 0.5% | 1 |
| 7 | HUASHAN HOSP PATHOL | 0 | 100% | 0.5% | 1 |
| 8 | IMAGE CYTOMETRY | 0 | 100% | 0.5% | 1 |
| 9 | KANTO TEISHIN HOSP DERMATOL SHINAGAWA KU | 0 | 100% | 0.5% | 1 |
| 10 | KANTO TEISHIN HOSP MED SHINAGAWA KU | 0 | 100% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000236972 | XIST//X CHROMOSOME INACTIVATION//TSIX |
| 2 | 0.0000106907 | ABT VIRALE TRANSFORMAT MECHANISMEN//AUSTRALIAN MEDICINAL PLANTS//CELLULAR AUTONOMY |
| 3 | 0.0000105760 | TETRAPLOID EMBRYO//TETRAPLOID EMBRYOS//ES MICE |
| 4 | 0.0000097048 | ACUTE ERYTHROLEUKEMIA//PURE ERYTHROID LEUKEMIA//ACUTE ERYTHROID LEUKEMIA |
| 5 | 0.0000081468 | CONTRALATERAL PROPHYLACTIC MASTECTOMY//BILATERAL BREAST CANCER//CONTRALATERAL BREAST CANCER |
| 6 | 0.0000079813 | LGR5//LGR4//GPR48 |
| 7 | 0.0000079223 | TETRASOMY 8//NEAR TETRAPLOIDY//TRISOMY 4 |
| 8 | 0.0000079185 | CLIN BREAST CARE PROJECT//16Q243//CHROMOSOMAL SCANNING |
| 9 | 0.0000079044 | LEUKEMIC BLAST PROGENITORS//L CFU//500 SHERBOURNE ST |
| 10 | 0.0000078509 | HCCR 1//HUMAN CERVICAL CANCER ONCOGENE//HCCR |